Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1384

M6903-hIgG2

Home » Antibodies » M6903-hIgG2

Background of M6903-hIgG2

T cell immunoglobulin and mucin domain-3 (TIM-3) represents an imperative immune checkpoint pivotal in regulating standard immune responses, yet opportunistically exploited by tumor cells to elude immune surveillance. Predominantly found on immune cells, particularly on dysfunctional and depleted T cells, TIM-3's interaction with its ligands precipitates a suppression of T cell activity. Enter antagonistic ligand-blocking anti-TIM-3 antibodies, such as M6903, which harbor immense potential to counteract T cell inhibition, reignite antigen-specific T cell functionality, and bolster the immune system's anti-tumor efficacy. M6903 stands out as a fully human anti-TIM-3 antibody devoid of effector function but boasting exceptional affinity and specificity towards TIM-3. Notably, M6903's pivotal action lies in obstructing the binding of TIM-3 to three of its ligands—phosphatidylserine (PtdSer), carcinoembryonic antigen cell adhesion-related molecule 1 (CEACAM1), and galectin 9 (Gal-9).

Specifications

Catalog Number:
KB-1384
Antibody Name:
M6903-hIgG2
Isotype:
Human IgG2, lambda
FC Muations:
Target:
TIM3
Species Reactivity:
Human
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
ELISA
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Lan Y, Zhang D, Xu C, Hance KW, Marelli B, Qi J, Yu H, Qin G, Sircar A, Hernández VM. Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β. Sci Transl Med. 2018;10(eaan5488). doi: 10.1126/scitranslmed.aan5488.
  2. Sabatos-Peyton CA, Brannetti B, Harris AS, Huber T, Pietzonka T, Mataraza JM, Blattler WA, Hicklin DJ, Vasquez M, DeKruyff RH, et al. Antibody molecules to tim-3 and uses thereof. United States patent US2015/0218274 A1. 2015.